Clinical Trial

Efficacy of CAD in Screening Colonoscopy to Reduce the Risk of Advanced Adenoma at 3 Years.

Study acronym: IA-COLO 2
Recruiting
View on ClinicalTrials.gov →
Summary
The occurrence of interval cancers after colonoscopy raises the possibility of missed lesions. High- performance computer aided diagnosis (CAD) systems have been specially designed for the detection of colorectal lesions (CAD for detection is named CADe). The use of CADe improves adenoma detection in screening colonoscopy. The potential of CADe system in reducing the rate of progression to advanced polyps or interval cancer between two colonoscopies remains still uncertain.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-12-09; most recent amendment 2026-03-13.
Status change: Not Yet Recruiting → Recruiting 2026-03-13
Trial Details
NCT Number NCT07299071
Lead Sponsor University Hospital, Bordeaux
Conditions Colonoscopy, Colorectal Neoplasms, Intestinal Polyps
Enrollment 592 participants
Start Date 2026-03-13
Primary Completion 2031-03 (estimated)
Study Completion 2031-03 (estimated)
Updated on ClinicalTrials.gov 2026-03-16